Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents. - Wikidata - wikimedia - TriplyDB

Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents.

Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents.

http://www.wikidata.org/entity/Q34025468

about

Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant study.Autologous peripheral blood stem cell transplantation in children and adolescents with non-Hodgkin lymphoma.Deficiency of CD73/ecto-5'-nucleotidase in mice enhances acute graft-versus-host disease Paediatric non-Hodgkin lymphoma - perspectives in translational biology Advances in hematopoietic stem cell transplantation in childhood and adolescent lymphomas.Alternate donor hematopoietic cell transplantation (HCT) in non-Hodgkin lymphoma using lower intensity conditioning: a report from the CIBMTR Autologous and allogeneic cellular therapies for high-risk pediatric solid tumors.Current status of allogeneic transplantation for aggressive non-Hodgkin lymphoma.Mature B-cell lymphoma and leukemia in children and adolescents-review of standard chemotherapy regimen and perspectives.Anaplastic large cell lymphoma in children and adolescents.XI. How to treat children and adolescents with relapsed non-Hodgkin lymphoma?Biomarkers in childhood non-Hodgkin's lymphomas.Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease.Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.Emerging immunotherapy in pediatric lymphoma.Current status and future directions of T-lymphoblastic lymphoma in children and adolescents.Recent molecular and therapeutic advances in B-cell non-Hodgkin lymphoma in children.Relapsed or Refractory Lymphoblastic Lymphoma in Children: Results and Analysis of 23 Patients in the EORTC 58951 and the LMT96 Protocols.Relapsed/refractory pediatric B-cell non-Hodgkin lymphoma treated with rituximab combination therapy: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group.Hematopoietic stem cell transplantation in relapsed ALK+ anaplastic large cell lymphoma in children and adolescents: a study on behalf of the SFCE and SFGM-TC.Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies.Clinical characteristics and treatment outcomes of children with anaplastic large cell lymphoma: a single center experience.Outcome of childhood relapsed or refractory mature B-cell non-Hodgkin lymphoma and acute lymphoblastic leukemia.Ten-year follow-up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation.Clinical impact of miR-223 expression in pediatric T-Cell lymphoblastic lymphoma.Pharmacotherapeutic Management of Pediatric Lymphoma.Risk factors predicting the survival of pediatric patients with relapsed/refractory non-Hodgkin lymphoma who underwent hematopoietic stem cell transplantation: a retrospective study from the Turkish pediatric bone marrow transplantation registry.European Society for Blood and Marrow Transplantation Analysis of Treosulfan Conditioning Before Hematopoietic Stem Cell Transplantation in Children and Adolescents With Hematological Malignancies.Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma.Long-term results of the AIEOP LNH-97 protocol for childhood lymphoblastic lymphoma.Haematopoietic stem cell transplantation for relapsed or refractory anaplastic large cell lymphoma: a study of children and adolescents in Japan.Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma.

P2860

Q26797513-16500DBA-84C7-4110-8BC6-890A76189648 Q35669884-6B09C952-8238-4B6F-85D1-C34B724155C7 Q35944560-E2BD0EF8-D5DA-4495-8AAB-506311180053 Q35995245-B538F45A-BC03-4AD7-8C8E-F576A25AA459 Q36889143-B7E13C28-BDD7-476F-9023-4B6556FEE347 Q36979074-E451F499-C60F-4D55-9C27-7F56BC0D34FE Q37490480-4D277520-7D76-46D1-A445-B6E1BB69A349 Q37716119-8ADA66C0-1610-45FF-BF37-EBA90D20F143 Q37938531-BDA48AD5-0A4D-4805-9C4A-2E322B6A775D Q38097544-3BEC464B-4CC5-49F9-AB28-D8B2D58A2433 Q38113829-13F0E5C2-5995-468C-B019-0A3639D319DC Q38115231-C885BD04-3371-4C19-9EFD-681110DA0F0F Q38138608-04687B3E-A7EB-4C78-8375-7A8D2A5DA15E Q38207137-C0CBFA87-52F1-4720-B583-BDAC2937BCA3 Q38387292-E29A1649-24A6-4BDF-8688-5DA6E344E614 Q38652326-E5C44287-560D-4927-AC5A-6844E151E54B Q38779952-29DE02E2-E300-4CF4-9F5A-1B50D0516F5D Q38782141-A4C413B9-9F0F-411D-8E51-3ECE5016A676 Q39869982-D865B89C-86A4-462D-98F1-D05538342ADB Q40695241-A0274AA5-DBB9-4C41-A24F-3D8BC62CEDA9 Q41141389-B24C4973-E480-4435-97BE-5E00FF14A645 Q41942675-C6282707-4F80-42FD-9E32-FCE1F59C8C9A Q42086879-6E00B28C-2859-4560-8403-FF9B8E0F2A5C Q44198884-C5323015-56EA-4B43-9365-6338DAAE00B2 Q44647479-1FD401B0-91C8-4DB3-9972-D21B91A9F462 Q47120665-7195CA08-8CD4-43C7-9B19-AC50A9E98FB5 Q48321203-1B5E8925-F569-4485-9AF4-EE8F3C35B60B Q48341313-0E11E1EA-7D99-4C7C-808D-EBD36CB89DAC Q50854536-3B8D1C19-D588-4C11-90C0-3D63E3E7BE56 Q50942188-79352834-28B3-48A3-BAE7-E31F88E475F9 Q51000439-9251847D-D91C-4E34-BD16-E47CAAA0DDE0 Q53255311-5EBD7D7E-DB81-4797-989F-E2B76DC3D8F5 Q54981113-55DEAA13-F95F-4997-805C-AA3AB9904E4E

P2860

Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents.

http://www.wikidata.org/entity/Q34025468

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Hematopoietic stem cell transp ...... a in children and adolescents.

@ast

Hematopoietic stem cell transp ...... a in children and adolescents.

@en

Hematopoietic stem cell transp ...... a in children and adolescents.

@nl

type

label

Hematopoietic stem cell transp ...... a in children and adolescents.

@ast

Hematopoietic stem cell transp ...... a in children and adolescents.

@en

Hematopoietic stem cell transp ...... a in children and adolescents.

@nl

prefLabel

Hematopoietic stem cell transp ...... a in children and adolescents.

@ast

Hematopoietic stem cell transp ...... a in children and adolescents.

@en

Hematopoietic stem cell transp ...... a in children and adolescents.

@nl

P1433

Q34025468-3436D586-F4B8-4020-A93B-623E9BBCE1E8

P1476

Q34025468-9F902F5E-8782-470B-8FC8-146461572293

P2093

Q34025468-0E00FC3E-BE25-4520-8C39-F4D6F376034F

Q34025468-19C9090B-B088-4C24-B649-996C3179BEFE

Q34025468-388C79DE-2DC8-44B3-8AB6-4B4688FAEC01

Q34025468-3F878087-AAD3-4BC6-B711-EB5AE6FFA924

Q34025468-94C2762D-0655-4120-B1D4-8615326D5B7D

Q34025468-94E3EEED-9DAF-4A89-ADA5-718950726D5B

Q34025468-D8D93102-263A-44D2-B9AF-170594103994

Q34025468-E1CF8ACE-65E6-4831-9FAC-DA4BBE666401

Q34025468-ED1295F3-006C-4DE7-960B-A7EC64D60123

Q34025468-F3A87E49-4B15-4DAC-9C6C-03CAA11B0587

P2860

Q34025468-163A7C6A-CDC7-4228-8D8A-6F814321D2A0

Q34025468-1DAAC4CF-617C-4E1E-9166-1EEF8B7C4EC3

Q34025468-1DD9D610-51D5-47B6-AE1C-A651DE8AEFF0

Q34025468-3C27D8C7-5DAB-4613-AD45-B43C21320831

Q34025468-5E49F088-0040-46E5-9679-9246C010886E

Q34025468-6E12A9CE-C394-4BA6-AD5E-F1BEEACFDC02

Q34025468-76A9C48B-783A-4A14-A991-BA534CC2CA44

Q34025468-7E74321F-5416-41E1-A0EA-95F2D4CC7A86

Q34025468-7EC75F25-732B-4B34-AE64-AA89EAB0B426

Q34025468-93A779D2-1C70-45F5-A5F6-FD0DD201AA4C

P304

Q34025468-7E35FD21-FA88-4CDF-86B4-8A59FDF5D066

P31

Q34025468-C593264B-80FE-428D-A3D5-41FBCCF8E855

P356

Q34025468-CF0A978D-EBA3-4A8C-9A7C-7726B202C350

P433

Q34025468-5AA3E2AC-2A9C-4675-95F0-9E9BA373736A

P478

Q34025468-757D7645-8FD6-4A59-92C1-426306282345

P577

Q34025468-53A4706F-1663-47EB-BD56-EF445E484431

P5875

Q34025468-2BFEF928-4B22-48CE-92C5-D4E944FFDE70

P698

Q34025468-CB3A42FF-930B-4B86-B78D-81CE374298E5

P921

Q34025468-E9591CC7-D15B-4AB7-A61A-A37E78BDBBC5

P932

Q34025468-9A51F09B-2700-4581-87C1-4F19E17C2BB7

P356

J.BBMT.2009.09.021

P1433

Biology of Blood and Marrow Transplantation

P1476

Hematopoietic stem cell transp ...... a in children and adolescents.

@en

P2093

Amanda M Termuhlen

http://www.w3.org/2001/XMLSchema#string

Bruce M Camitta

http://www.w3.org/2001/XMLSchema#string

Gregory A Hale

http://www.w3.org/2001/XMLSchema#string

Jean E Sanders

http://www.w3.org/2001/XMLSchema#string

Mary Eapen

http://www.w3.org/2001/XMLSchema#string

Mei-Jie Zhang

http://www.w3.org/2001/XMLSchema#string

Mitchell S Cairo

http://www.w3.org/2001/XMLSchema#string

Robert J Hayashi

http://www.w3.org/2001/XMLSchema#string

Stella M Davies

http://www.w3.org/2001/XMLSchema#string

Thomas G Gross

http://www.w3.org/2001/XMLSchema#string

P2860

Pathophysiology and treatment of graft-versus-host disease.

Childhood and adolescent large-cell lymphoma (LCL): a review of the Children's Cancer Group experience.

Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience.

Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents.

Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients.

1994 Consensus Conference on Acute GVHD Grading

Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive first-line treatment: a population-based analysis of the Austrian Cooperative Study Group.

Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III tri

Non-Hodgkin's lymphoma in childhood.

Outcome of relapsed or refractory childhood B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin's lymphoma treated with the UKCCSG 9003/9002 protocols.

P304

223-230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2009.09.021

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26866330

http://www.w3.org/2001/XMLSchema#string

P698

19800015

http://www.w3.org/2001/XMLSchema#string

P921

P932

2911354

http://www.w3.org/2001/XMLSchema#string